If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmmerson Plc Regulatory News (EML)

Share Price Information for Emmerson Plc (EML)

Share Price is delayed by 15 minutes
Get Live Data
2.10    0.00 (0.00%)
Bid:
2.00
Ask:
2.20
Spread: 0.20 (10.00%)
Market Cap: £28.06m
EML Live PriceLast checked at - London Stock Exchange

Intraday Emmerson Plc Share Chart

Litigation Funding Update

17 Mar 2025 07:00

RNS Number : 8035A
Emmerson PLC
17 March 2025
 

Emmerson Plc / Ticker: EML / Index: LSE / Sector: Mining

 

17 March 2025

Emmerson PLC

("Emmerson" or the "Company")

Litigation Funding Update

Emmerson Plc, the Moroccan focused potash development company, is pleased to announce that, further to the announcement on 2 January 2025, the Company has drawn down the first tranche of funding under the Capital Provision Agreement ("CPA") which will provide the Company with up to US$11,000,000 in both litigation finance capital and working capital.

Alongside the draw down of the first tranche of funding from the CPA, the Company and its subsidiaries in the UK and Morocco provide notice that they have granted certain securities and charges over their assets to the funding counterparty in relation to amounts drawn down. The granting of such security is considered ordinary course for litigation funding arrangements and shall not be enforced so long as the Company continues to meet its obligations under the CPA as intended.

The initial drawdown will cover all legal costs to date and ensure that the Company's legal team can complete the next steps in the dispute process, for which preparation is well underway.

The Company will provide further updates in due course.

 

**ENDS**

For further information, please visit www.emmersonplc.com, follow us on Twitter (@emmerson_plc), or contact: 

 

Emmerson Plc

Graham Clarke / Hayden Locke

+44 (0) 207 138 3204

Panmure Liberum Limited (Nominated Adviser and Joint Broker)

Scott Mathieson / Will King

+44 (0) 20 3100 2000

Shard Capital Partners LLP (Joint Broker)

Damon Heath / Isabella Pierre

+44 (0) 207 186 9927

Notes to Editors

Emmerson has been focused on advancing the Khemisset project ("Khemisset" or the "Project") in Morocco into a low cost, high margin supplier of potash, and the first primary producer on the African continent. With an initial 19-year life of mine, the development of Khemisset is expected to deliver long-term investment and financial contributions to Morocco including the creation of permanent employment, taxation, and a plethora of ancillary benefits. As a UK-Moroccan partnership, the Company has been working towards significant international investment over the life of the mine.

Morocco is one of the leading phosphate producers globally and the development of this mine is set to consolidate its position as the most important fertiliser producer in Africa. The Project has a large JORC Resource Estimate (2012) of 537Mt @ 9.24% K2O, with significant additional exploration potential, and is perfectly located to support the expected growth of African fertiliser consumption whilst also being located on the doorstep of European markets. The need to feed the world's rapidly increasing population is driving demand for potash and Khemisset is well placed to benefit from the opportunities this presents. The Feasibility Study released in June 2020 indicated the Project has the potential to be among the lowest capital cost development stage potash projects in the world and also, as a result of its location, one of the highest margin projects. Updated financial estimates published in February 2024 indicated a net present value of US$2.2 billion, with an internal rate of return of approximately 40%.

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDZZGMFVDGGKZM
Date   Source Headline
3rd Jan 20237:00 amRNSAppointment of Liberum as Nominated Advisor
21st Nov 20227:00 amRNSPotash and Salt Offtake MOUs
27th Sep 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20221:45 pmRNSResults of REX Retail Offer & Total Voting Rights
26th Sep 20227:02 amRNSREX Retail Offer
26th Sep 20227:01 amRNSRenewal of Strategic Investment & Equity Placing
26th Sep 20227:00 amRNSInterim Results for the six months to 30 June 2022
16th Aug 20224:18 pmRNSExercise of Options & Director/PDMR Shareholding
22nd Jul 20229:00 amRNSShare Options Scheme & Director Shareholdings
19th Jul 20225:05 pmRNSReplacement: Director/PDMR Shareholding
18th Jul 20224:00 pmRNSDirector/PDMR Shareholding
11th Jul 20227:00 amRNSQ2 Activities Update
7th Jul 202212:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSExercise of Warrants and Issue of Shares
13th Jun 20227:00 amRNSNotice of AGM and Posting of Annual Report
31st May 20227:00 amRNSAudited Results for the year ended 31 Dec 2021
31st Mar 20227:00 amRNSQ1 Activities Update
15th Mar 20227:00 amRNSGrant of Share Options
21st Feb 20227:00 amRNSAppointment of Chief Financial Officer
16th Feb 20227:00 amRNSAppointment of Corporate Broker
27th Jan 20227:00 amRNSBasic Engineering Packages Awarded to Reminex S.A
25th Jan 20221:00 pmRNSPart Exercise of Options and Issue of Shares
31st Dec 20217:00 amRNSEnd of Year Newsletter
6th Dec 202112:45 pmRNSResult of AGM
6th Dec 202112:31 pmRNSResult of General Meeting
2nd Dec 20217:00 amRNSOperational Update: Khemisset Potash Project
29th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSIssue of Equity & Total Voting Rights
12th Nov 20217:00 amRNSInvestor Presentation
11th Nov 202110:30 amRNSNotice of AGM
11th Nov 20217:00 amRNSDirector/PDMR Shareholding
10th Nov 20219:05 amRNSSecond Price Monitoring Extn
10th Nov 20219:00 amRNSPrice Monitoring Extension
10th Nov 20217:00 amRNSStrategic Investment of up to US$46.75m
30th Sep 20217:01 amRNSOperational Update: Khemisset Potash Project
30th Sep 20217:00 amRNSInterim Results
12th Jul 20217:00 amRNSAppointment of Non-Exec Director & Board Changes
24th Jun 20217:00 amRNSKhemisset Potash Project Update
4th Jun 202111:30 amRNSDirector/PDMR Shareholding
3rd Jun 20212:05 pmRNSSecond Price Monitoring Extn
3rd Jun 20212:00 pmRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSExercise of Warrants and Issue of Shares
21st May 20218:15 amRNSShareholder Call
18th May 20211:15 pmEQSHardman & Co Research: Emmerson Plc (EML): A competitively well-placed potash play
17th May 20217:00 amRNSFinal Results
29th Apr 202111:00 amRNSYellowstone Advisory Event
27th Apr 202112:40 pmEQSHardman & Co Research : Hardman & Co Video Event | Emmerson Plc - Investor Forum
27th Apr 20217:00 amRNSAdmission to AIM and Appointment of Chairman
21st Apr 20211:32 pmRNSSchedule One update - Emmerson plc
15th Apr 20217:00 amRNSUpdate on Phased Development Strategy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.